Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist

Medical Hypotheses

Volumn 65, Issue 1, 2005, Pages 155-157

  Nakamura, K ^a   Yamagishi, S ^a   Inoue, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZELNIDIPINE; CALCIUM ANTAGONIST; DIHYDROPYRIDINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; AZETIDINECARBOXYLIC ACID; BIOLOGICAL MARKERS; CALCIUM; CARDIOVASCULAR DISEASES; CELLS, CULTURED; CHEMOKINE CCL2; DIABETES MELLITUS; DIHYDROPYRIDINES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; INSULIN RESISTANCE; INTERLEUKIN-8; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 18944368015     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.12.007     Document Type: Article

References (14)

1. A.J. Scheen Management of the metabolic syndrome Minerva Endocrinol 29 2004 31 45
2. J.M. Fernandes-Real, and W. Ricart Insulin resistance and chronic cardiovascular inflammatory syndrome Endocr Rev 24 2003 278 301
3. J.R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol 286 2004 H1597 1602
4. K.E. Watson, A.L. Peters Harmel, and G. Matson Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance Cardiovasc Pharmacol Ther 8 2003 253 260
5. S.E. Borst The role of TNF-alpha in insulin resistance Endocrine 23 2004 177 182
6. B.E. Wisse The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity J Am Soc Nephrol 15 2004 2792 2800
7. G.S. Hotamisligil, D.L. Murray, L.N. Choy, and B.M. Spiegelman Tumor necrosis factor-alpha inhibits signaling from the insulin receptor Proc Natl Acad Sci USA 91 1994 4854 4858
8. L. Branen, L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice Arterioscl Thromb Vasc Biol 24 2004 2137 2142
9. S. Yamagishi, Y. Inagaki, K. Nakamura, and T. Imaizumi Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-α-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties J Cardiovasc Pharmacol 43 2004 724 730
10. R.E. Gerszten, E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, M.A. Gimbrone Jr., A.D. Luster, F.W. Luscinskas, and A. Rosenzweig MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions Nature 398 1999 718 723
11. T.L. Yeu, X. Wang, C.P. Sung, B. Olson, P.J. McKenna, J.L. Gu, and G.Z. Feuerstein Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells Circ Res 75 1994 1 7
12. R. Deo, A. Khera, D.K. McGuire, S.A. Murphy, P. Meo Neto Jde, D.A. Morrow, and J.A. de Lemos Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol 44 2004 1812 1818
13. A. Ceriello, and E. Motz Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscl Throm Vasc Biol 24 2004 816 823
14. D.W. Laight, K.M. Desai, N.K. Gopaul, E.E. Anggard, and M.J. Carrier F2-isoprostane evidence of oxidative stress in the insulin resistant, obese Zucker rat: effects of Vitamin E Eur J Pharmacol 377 1999 89 92